title: Pulmonary hypertension in interstitial lung disease.
abstract: OBJECTIVE
  Exercise impairment and pulmonary hypertension are common features of interstitial lung disease. Antifibrotic therapies for interstitial lung disease remain unproved; therefore, some interest has been focused on treating the pulmonary vascular impairment these diseases.
  
  
  RESULTS
  Patients with pulmonary hypertension secondary to idiopathic pulmonary fibrosis may have normal resting pulmonary artery pressure, but it often rises with exercise. Exercise impairment in idiopathic pulmonary fibrosis has a strong correlation with the degree of pulmonary artery pressure elevation, and hypoxemia, a hallmark of pulmonary hypertension, strongly correlates with survival.
  
  
  CONCLUSIONS
  Small case series have shown that some patients improve on receiving therapy for pulmonary hypertension secondary to interstitial lung disease. These findings suggest that larger treatment trials for medications targeting pulmonary hypertension in interstitial lung disease are warranted.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA. strangec@musc.edu
authors.forename: Charlie
authors.initials: C
authors.lastname: Strange
authors.forename: Kristin B
authors.initials: KB
authors.lastname: Highland
mesh_terms: D005080:Exercise Test; D017079:Exercise Tolerance; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D000860:Hypoxia / Q000209:etiology; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000473:pathology / Q000503:physiopathology